Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177600 · ClinicalTrials.gov registry record · NA
TransHealthGUIDE: Transforming Health for Gender-Diverse Young Adults
A NA study of Gender Identity and Transgender Persons, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06177600 is a NA study of Gender Identity and Transgender Persons that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 500 participants, above the 120-participant average among 3 other Gender Identity trials with a reported enrollment target (317% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06177600, a NA study of Gender Identity and Transgender Persons, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial to test the effectiveness of an interactive educational app-based digital intervention that provides knowledge and support to transgender and gender-diverse (TGD) young adults ages 18-29 years and their caregivers. The goal of the study is to examine the effects of exposure to the app on TGD young adult mental health outcomes. Participants will be randomized to an Immediate Arm (access to a digital platform, plus usual care) or a Deferred Arm (usual care; access to the digital platform at 6 mo). Usual care consists of access to published resources and community support organizations, if available. The list of resources will include contact information for a suicide prevention hotline. For each Arm, the intervention period will last 6 months, followed by 6 months of observation, during which access to the intervention is maintained. Assessments will be performed at baseline, 3, 6, and 12 months to document changes in mental health outcomes, and the two groups will be compared. The investigators plan to enroll 500 TGD young adults and their caregivers, with at least 50% (250 participants) to identify as Black, Indigenous, People of Color (BIPOC) and 50% (125 TGD young adults, 125 caregivers) to be young adult-caregiver dyads. Ongoing process reassessments will be performed to maximize effectiveness of the intervention, including focus groups and in-depth interviews with TGD young adults, caregivers, and providers, as well as analysis of data collected through the digital platform and participant surveys. Investigators will account for sociodemographic characteristics such as race and ethnicity, age, gender identity, education status, existing mental health conditions, and history of suicidal ideation or attempt. Data will be analyzed across racial minority groups to ensure that the intervention is effective for all racial minorities; if there are discrepancies in effectiveness, additional mixed methods evaluation will be perfor
Conditions Studied
Interventions
- BEHAVIORAL Interactive educational digital platform for transgender and gender-diverse (TGD) young adults and caregivers
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-04-23 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06177600
The ClinicalTrials.gov registry entry for NCT06177600 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 120-participant average among 3 other Gender Identity trials with a reported enrollment target (317% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gender Identity appearing as the primary indexed condition, and to 1 intervention - of which Interactive educational digital platform for transgender and gender-diverse (TGD) young adults and caregivers is the first listed.
NCT06177600 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06177600 about?
NCT06177600 is a clinical study titled "TransHealthGUIDE: Transforming Health for Gender-Diverse Young Adults". This is a randomized controlled trial to test the effectiveness of an interactive educational app-based digital intervention that provides knowledge and support to transgender and gender-diverse (TGD) young adults ages 18-29 years and their caregivers. The goal of the study is to examine the effects...
What is the current status of trial NCT06177600?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-04-23. Estimated completion is 2026-08-31.
What conditions does trial NCT06177600 study?
This clinical trial studies the following conditions: Gender Identity, Transgender Persons, Health Services for Transgender Persons.
What interventions are being tested in trial NCT06177600?
The interventions under investigation include: Interactive educational digital platform for transgender and gender-diverse (TGD) young adults and caregivers (BEHAVIORAL).
Who is sponsoring clinical trial NCT06177600?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06177600 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gender Identity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.